Expression Modulation of Immune Checkpoint Molecules by Ibrutinib and Everolimus Through STAT3 in MCF-7 Breast Cancer Cells

Tumor-targeted therapy with small-molecule inhibitors (SMIs) has been demonstrated to be a highly effective therapeutic strategy for various cancers. However, their possible associations with immune evasion mechanisms remain unknown. This study examined the association of inhibitors of the protein k...

Descripción completa

Detalles Bibliográficos
Autores principales: Soltanshahi, Mohsen, Taghiloo, Saeid, Asgarian-Omran, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Brieflands 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293249/
https://www.ncbi.nlm.nih.gov/pubmed/35873012
http://dx.doi.org/10.5812/ijpr-127352

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293249/
https://www.ncbi.nlm.nih.gov/pubmed/35873012
http://dx.doi.org/10.5812/ijpr-127352

Ejemplares similares